<p>Ascletis Pharma Inc. has filed a next day disclosure return with the Hong Kong Stock Exchange, announcing the repurchase of 100,000 ordinary shares at a total price of HKD 1,152,880. The repurchased shares are intended for cancellation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251230-11970711), on December 30, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

01672

<p>Ascletis Pharma Inc. has disclosed the repurchase of 100,000 ordinary shares for HKD 1,152,880 through a filing with the Hong Kong Stock Exchange. The shares are intended for cancellation.</p>

Ascletis Pharma Files HKEX Disclosure on Repurchase of 100,000 Shares for HKD 1.15 Million